LBRX
LB Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
6.60 / 10
Outperform
Capital flow assessment yields 7.7/10, denoting robust fund flow characteristics. Strengths in overall, block, Medium, and Extra-large trends confront pressures from Small and Large patterns, resulting in positive liquidity outlook. Professional analyst opinion suggests overwhelmingly bullish analyst consensus, showing strong conviction. Distribution pattern: Strong Buy(100.0%) based on 1 research evaluations, supported by 5.49 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-11
InstitutionStifel
Times predicted2
Historical Win Rate100.0%
What is the market sentiment for LBRX?
- LBRX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.60/10 (Outperform).
